Dobson R, Holden D, Vickaryous N, Bestwick J, et al. A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis. Mult Scler 2023 Dec 22:13524585231215268. doi: 10.1177/13524585231215268.
PMID: 38131621